White House Backs Off Proposals to Reduce Biologic Drug Exclusivity

Drug Industry Daily
A A
After years of pressure from lawmakers and drugmakers, the Obama administration appears to be surrendering its push for a reduced seven-year exclusivity period for biologic drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily